Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02432482 · ClinicalTrials.gov registry record · NA
A Mobile Intervention to Promote Cessation in HIV-infected Smokers
A NA study of Tobacco Use and HIV-1-infection, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02432482: Completed NA study of Tobacco Use and HIV-1-infection, sponsored by Montefiore Medical Center.
NCT02432482 is a NA study of Tobacco Use and HIV-1-infection that has completed, run by Montefiore Medical Center. The registered enrollment target is 100 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02432482, a NA study of Tobacco Use and HIV-1-infection, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to adapt an existing web-based tobacco treatment program for HIV-infected smokers into a mobile intervention delivered via smartphone. After the adaptation is completed, the investigators will test the program's efficacy at promoting abstinence in a randomized controlled trial.
Conditions Studied
Interventions
- BEHAVIORAL Standard care
- BEHAVIORAL mobile Positively Smoke Free (mPSF)
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-04 |
| Phase | NA |
What the finished NCT02432482 record still lists
NCT02432482 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Standard care is the first listed.
NCT02432482 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02432482 about?
NCT02432482 is a clinical study titled "A Mobile Intervention to Promote Cessation in HIV-infected Smokers". The purpose of this study is to adapt an existing web-based tobacco treatment program for HIV-infected smokers into a mobile intervention delivered via smartphone. After the adaptation is completed, the investigators will test the program's efficacy at promoting abstinence in a randomized controlled...
What is the current status of trial NCT02432482?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-12. Estimated completion is 2017-04.
What conditions does trial NCT02432482 study?
This clinical trial studies the following conditions: Tobacco Use, HIV-1-infection.
What interventions are being tested in trial NCT02432482?
The interventions under investigation include: Standard care (BEHAVIORAL), mobile Positively Smoke Free (mPSF) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02432482?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02432482 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02432482's enrollment target sits among peer trials
100 39th of 76 higher than 36 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia